Fundraising FoxLyric
2 known investors
Find your way into Lyric
Sign up to see every warm intro you have to Lyric
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lyric team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lyric Bio develops tissue-engineered bioreactors that use a proprietary laser-printed cellular substrate to grow high-density human cells and produce human immunoglobulin (IvIg, ScIg) from a single donor. The company aims to reduce Ig therapy's dependence on blood and plasma donations and enable scalable manufacturing of complex donor-derived biologics.
Investors · 2
Draper Associateslisted by Draper AssociatesSan Mateo · $500K – $5M
How we know: Draper Associates's portfolio page · Not right? Tell us
The Venture Collectivelisted by The Venture CollectiveMiami Beach · $100K – $500K
How we know: The Venture Collective's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Lyric do?
- Lyric Bio develops tissue-engineered bioreactors that use a proprietary laser-printed cellular substrate to grow high-density human cells and produce human immunoglobulin (IvIg, ScIg) from a single donor. The company aims to reduce Ig therapy's dependence on blood and plasma donations and enable scalable manufacturing of complex donor-derived biologics.
- Who are Lyric's investors?
- Lyric's investors include Draper Associates, The Venture Collective.